FDA可用性指南
VIP免费
Contains Nonbinding Recommendations
Applying Human Factors and
Usability Engineering to Medical
Devices
Guidance for Industry and Food
and Drug Administration Staff
Document issued on: February 3, 2016
As of April 3, 2016, this document supersedes “Medical Device Use-Safety:
Incorporating Human Factors Engineering into Risk Management” issued
July 18, 2000.
The draft of this document was issued on June 21, 2011.
For questions regarding this document, contact the Human Factors Premarket Evaluation
Team at (301) 796-5580.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Devices and Radiological Health
Office of Device Evaluation
Contains Nonbinding Recommendations
Preface
Public Comment
You may submit electronic comments and suggestions at any time for Agency consideration to
http://www.regulations.gov . Submit written comments to the Division of Dockets
Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305),
Rockville, MD 20852. Identify all comments with the docket number FDA-2011-D-0469.
Comments may not be acted upon by the Agency until the document is next revised or updated.
Additional Copies
Additional copies are available from the Internet. You may also send an e-mail request to
CDRH-Guidance@fda.hhs.gov to receive a copy of the guidance. Please use the document
number 1757 to identify the guidance you are requesting.
Contains Nonbinding Recommendations
Table of Contents
Contents
1.
Introduction __________________________________________________________ 1
2.
Scope _______________________________________________________________ 1
3. Definitions ___________________________________________________________ 2
3.1 Abnormal use __________________________________________________________ 2
3.2 Critical task ____________________________________________________________ 3
3.3 Formative evaluation ____________________________________________________ 3
3.4 Hazard ________________________________________________________________ 3
3.5 Hazardous situation _____________________________________________________ 3
3.6 Human factors engineering _______________________________________________ 3
3.7 Human factors validation testing ___________________________________________ 3
3.8 Task __________________________________________________________________ 3
3.9 Use error ______________________________________________________________ 3
3.10 Use safety ______________________________________________________________ 3
3.11 User ___________________________________________________________________ 3
3.12 User interface___________________________________________________________ 4
4. Overview ____________________________________________________________ 4
4.1 HFE/UE as Part of Risk Management ______________________________________ 4
4.2 Risk Management _______________________________________________________ 6
5. Device Users, Use Environments and User Interface _________________________ 7
5.1 Device Users ____________________________________________________________ 9
5.2 Device Use Environments ________________________________________________ 10
5.3 Device User Interface ___________________________________________________ 10
6. Preliminary Analyses and Evaluations ___________________________________ 11
6.1 Critical Task Identification and Categorization _____________________________ 12
6.1.1 Failure mode effects analysis _________________________________________________ 12
6.1.2 Fault tree analysis __________________________________________________________ 13
6.2 Identification of Known Use-Related Problems ______________________________ 13
6.3 Analytical Approaches to Identifying Critical Tasks _________________________ 13
6.3.1 Task Analysis _____________________________________________________________ 14
6.3.2 Heuristic Analysis __________________________________________________________ 15
6.3.3 Expert Review_____________________________________________________________ 15
6.4 Empirical Approaches to Identifying Critical Tasks __________________________ 15
6.4.1 Contextual Inquiry _________________________________________________________ 16
6.4.2 Interviews ________________________________________________________________ 16
6.4.3 Formative Evaluations ______________________________________________________ 16
6.4.3.1 Cognitive Walk-Through _________________________________________________ 18
摘要:
展开>>
收起<<
ContainsNonbindingRecommendationsApplyingHumanFactorsandUsabilityEngineeringtoMedicalDevicesGuidanceforIndustryandFoodandDrugAdministrationStaffDocumentissuedon:February3,2016AsofApril3,2016,thisdocumentsupersedes“MedicalDeviceUse-Safety:IncorporatingHumanFactorsEngineeringintoRiskManagement”issuedJ...
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
纯化水中国药典2020版与2025版GAP分析VIP免费
2025-04-18 381 -
无菌检查法对比表(2025版药典 VS 2020版药典)
2025-09-27 594 -
1101无菌检查法对比表(2025版药典 VS 2020版药典)
2025-09-29 533 -
1143 细菌内毒素检查法对比表(2025版药典 VS 2020版药典)
2025-09-29 999+ -
TR-26-2025-Sterilizing-Filtration-of-Liquids液体的灭菌过滤(中英文对照版)VIP专享
2025-11-06 513 -
TR-26-2025-Sterilizing-Filtration-of-Liquids液体的灭菌过滤(英文版)VIP免费
2025-11-06 172 -
PDA-TR49-生物清洁验证-中英文翻译
2025-11-19 167 -
注射用药品的目视检查-第五版-2025.10_中文VIP免费
2025-11-25 81 -
硫酸艾玛昔替尼片(CXHS2300097)说明书VIP免费
2025-11-26 430 -
PDA TR60 Process Validation A Lifecycle Approach 2026VIP免费
2026-03-19 83
作者:trty876...
分类:法规规范
价格:50质量币
属性:49 页
大小:918.39KB
格式:PDF
时间:2026-03-24

